Search results
Results from the WOW.Com Content Network
Postmenopausal women have a higher risk of gout. Reproductive factors like starting your period later, entering menopause earlier, and using oral contraceptives or hormone replacement therapy have ...
Ultimately, the study found disparate results for all cause mortality with HRT, finding it to be lower when HRT was begun during ages 50–59, but higher when begun after age 60. The authors of the study recommended that women with non-surgical menopause take the lowest feasible dose of hormones for the shortest time to minimize risk. [97]
Women's Estrogen Lipid-Lowering Hormone Atherosclerosis Regression Trial (WELL-HART) Women's Health Initiative Estrogen Study (WHI-E) Women's Health Initiative Estrogen + Progestin Study (WHI-EP) Women's Health, Osteoporosis, Progestin, Estrogen (Women's HOPE) Women's International Study of Long-Duration Oestrogen After Menopause (WISDOM)
In transgender women, estradiol valerate given by intramuscular injection is usually used at a dosage of 5 to 20 mg, but up to 30 to 40 mg, once every 2 weeks. [30] [31] [29] Estradiol valerate has also been used at a dose of 10 to 40 mg by intramuscular injection to limit bleeding in women with hemorrhage due to dysfunctional uterine bleeding.
Women with vasomotor symptoms during menopause seem to have an especially unfavorable cardiometabolic profile, [36] as well as women with premature onset of menopause (before 45 years of age). [37] These risks can be reduced by managing risk factors, such as tobacco smoking, hypertension , increased blood lipids and body weight.
Age. The risk for most arthritis types increases with age. Research from the Centers for Disease Control and Prevention (CDC) noted that 3.6 percent of adults aged 18 to 34 had arthritis, compared ...
Rates of gout approximately doubled between 1990 and 2010. [17] This rise is believed to be due to increasing life expectancy, changes in diet and an increase in diseases associated with gout, such as metabolic syndrome and high blood pressure. [25] Factors that influence rates of gout include age, race, and the season of the year.
Menopause is a natural decline in the ovarian function of women who reach the age between 45 and 54 years. "About 25 million women pass through menopause worldwide each year, and it has been estimated that, by the year 2030, the world population of menopausal and postmenopausal women will be 1.2 billion, with 47 million new entrants each year."